Literature DB >> 16880353

Alzheimer's disease and the aging brain.

Robert D Terry1.   

Abstract

The frequencies of each of the several types of dementia are enumerated, showing that Alzheimer's disease is present in about 80% of cases. Cerebral changes associated with cognitively normal aging include shrinkage of large cortical neurons but not a significant loss of total neuronal number. Nevertheless, the population density of synapses measured by confocal microscopy does decline significantly in normal aging. The classical lesions of Alzheimer's disease are neuritic plaques and neurofibrillary tangles, and their frequency correlates with declining cognitive measures. Although amyloid is prominent in plaques, it is probably not the agent of destruction. That role seems to be held by Abeta oligomers. The strongest structural correlate with cognitive tests is synapse loss, which is probably caused by Abeta oligopeptides in the terminal axons and dendrites.

Entities:  

Mesh:

Year:  2006        PMID: 16880353     DOI: 10.1177/0891988706291079

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  37 in total

1.  Effect of a medical food on body mass index and activities of daily living in patients with Alzheimer's disease: secondary analyses from a randomized, controlled trial.

Authors:  P J G H Kamphuis; F R J Verhey; M G M Olde Rikkert; J W R Twisk; S H N Swinkels; P Scheltens
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

2.  Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial.

Authors:  P J G H Kamphuis; F R J Verhey; M G M Olde Rikkert; J W R Twisk; S H N Swinkels; P Scheltens
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

Review 3.  Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

Authors:  Richard J Wurtman; Mehmet Cansev; Toshimasa Sakamoto; Ismael Ulus
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

Review 4.  Therapeutic strategies for Alzheimer's disease.

Authors:  Donna M Barten; Charles F Albright
Journal:  Mol Neurobiol       Date:  2008-06-26       Impact factor: 5.590

5.  Microarray profile of brain aging-related genes in the frontal cortex of SAMP8.

Authors:  Shao-Chun Chen; Gang Lu; Chu-Yan Chan; Yangchao Chen; Hua Wang; David Tai-Wai Yew; Zhong-Tang Feng; Hsiang-Fu Kung
Journal:  J Mol Neurosci       Date:  2009-10-17       Impact factor: 3.444

6.  Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology.

Authors:  Sonia Do Carmo; Gogce Crynen; Tiffany Paradis; Jon Reed; M Florencia Iulita; Adriana Ducatenzeiler; Fiona Crawford; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

7.  Memory and neurogenesis in aging and Alzheimer's disease.

Authors:  Jesus Avila; Ricardo Insausti; Joaquin Del Rio
Journal:  Aging Dis       Date:  2010-05-21       Impact factor: 6.745

8.  Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals.

Authors:  Pavel Katsel; Weilun Tan; Vahram Haroutunian
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

9.  Neuroinflammation resulting from covert brain invasion by common viruses - a potential role in local and global neurodegeneration.

Authors:  Jeannine A Majde
Journal:  Med Hypotheses       Date:  2010-03-16       Impact factor: 1.538

10.  Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

Authors:  Corinne G Jolivalt; Rosemarie Hurford; Corinne A Lee; Wilmar Dumaop; Edward Rockenstein; Eliezer Masliah
Journal:  Exp Neurol       Date:  2009-11-18       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.